Table 1.
All tumors (n = 361) | |||
---|---|---|---|
Age (mean, min-max, SD) | 57.5 | 16–89 | SD 13.2 |
Age; grouped | n | % | |
<58 years old | 168 | 46.5 | |
≥58 years old | 192 | 53.2 | |
Missing | 1 | 0.3 | |
Tumor type | n | % | |
Serous adenocarcinoma | 210 | 64.4 | |
Other | 116 | 35.6 | |
- Mucinous adenocarcinoma | 40 | 12.3 | |
- Endometrioid adenocarcinoma | 51 | 15.6 | |
- Clear cell carcinoma | 22 | 6.8 | |
- Undifferentiated | 3 | 0.9 | |
Missing | 35 | ||
FIGO-stage | n | % | |
Stage I | 70 | 19.4 | |
Stage II | 30 | 8.3 | |
Stage III | 205 | 56.8 | |
Stage IV | 54 | 15.0 | |
Missing | 2 | 0.6 | |
Grade | n | % | |
Grade I | 57 | 15.8 | |
Grade II | 96 | 26.6 | |
Grade III | 160 | 44.3 | |
Undifferentiated | 15 | 4.2 | |
Missing | 33 | 9.1 | |
Rest tumor after primary surgery | n | % | |
Yes | 224 | 62.0 | |
No | 125 | 34.6 | |
Missing | 12 | 3.3 | |
Size of rest tumor | n | % | |
<2 cm | 168 | 46.5 | |
≥2 cm | 163 | 45.2 | |
Missing | 30 | 8.3 | |
Progression free survival (months) | |||
(mean, min-max, SD) | 29.6 | 0–207 | SD 36.3 |